Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trial. [PDF]
Urwyler P +14 more
europepmc +1 more source
Correction to “Identification of the Minimum Region of Bordetella pertussis Vag8 Required for Interaction With C1 Inhibitor” [PDF]
openalex +1 more source
Electroconvulsive Therapy in Patients with C1 Inhibitor Deficiency: A Major or Minor Procedure? [PDF]
Ariel Callero +5 more
openalex +1 more source
Utilizing dual‐site fiber photometry, this study examines cortico‐striatal coupling with cell type resolution, identifying behavior‐ and cell type‐specific cortico striatal decoupling and its dopamine‐dependent mechanism in a Parkinson's disease mouse model.
Xu‐Ran Yao +4 more
wiley +1 more source
Expanding the Genetic and Clinical Spectrum of Hereditary Angioedema with Normal C1 Inhibitor: Novel Variants and Treatment Insights. [PDF]
Gao H +18 more
europepmc +1 more source
Pregnancy in women with Hereditary Angioedema due to C1-inhibitor deficiency: Results from the ITACA cohort study on outcome of mothers and children with in utero exposure to plasma-derived C1-inhibitor. [PDF]
Triggianese P +15 more
europepmc +1 more source
Μελέτη του πολυμορφισμού V480M-SERPING1στο κληρονομικό αγγειοοίδημα και σε λοιμώξεις του ανώτερου αναπνευστικού [PDF]
Αβραμούλη, Αντιγόνη
core +1 more source
An evolutionary molecular dynamics platform is used to design P1.6, a membrane‐active peptide that senses lipid packing defects in viral envelopes. P1.6 adopts a stabilized α‐helical structure upon membrane contact, disrupts virus‐like liposomes, and damages HIV‐1 particles.
Pascal von Maltitz +10 more
wiley +1 more source
C1 inhibitor deficient hereditary angioedema is related to endothelial dysfunction in young adult and middle-aged patients. [PDF]
Atay Sensoy GG +7 more
europepmc +1 more source
Successful use of lanadelumab in a patient with hereditary angioedema with normal C1 inhibitor and negative genetic testing. [PDF]
Adatia A, Ritchie B.
europepmc +1 more source

